CRP and hepatocellular carcinoma: Since the classification of patients into intermediate- and high-risk mGPS groups (mGPS>0) depends on an elevated CRP (>10 mg/L), it remains uncertain whether mGPS is reliable in HCC patients with severely reduced liver function (13).